Guardant Health Valuation
| GH Stock | USD 35.61 0.51 1.45% |
At this time, the firm appears to be undervalued. Guardant Health retains a regular Real Value of $42.55 per share. The prevalent price of the firm is $35.61. Our model calculates the value of Guardant Health from evaluating the firm fundamentals such as return on equity of -6.09, and Return On Asset of -0.16 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Guardant Health's valuation include:
Price Book 55.6696 | Enterprise Value 4.7 B | Enterprise Value Ebitda (5.40) | Price Sales 6.3557 | Enterprise Value Revenue 6.7563 |
Undervalued
Today
Please note that Guardant Health's price fluctuation is very steady at this time. Calculation of the real value of Guardant Health is based on 3 months time horizon. Increasing Guardant Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardant Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardant Stock. However, Guardant Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.61 | Real 42.55 | Target 53.0 | Hype 36.99 | Naive 35.82 |
The intrinsic value of Guardant Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Guardant Health's stock price.
Estimating the potential upside or downside of Guardant Health helps investors to forecast how Guardant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardant Health more accurately as focusing exclusively on Guardant Health's fundamentals will not take into account other important factors: When choosing an evaluation method for Guardant Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Guardant Health Cash |
|
Guardant Valuation Trend
Guardant Health's real value analysis enables investors to forecast the earnings more efficiently. Using both Guardant Health's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Guardant Valuation Data Drivers
Guardant Health Total Value Analysis
Guardant Health is currently forecasted to have takeover value of 4.68 B with market capitalization of 4.4 B, debt of 1.35 B, and cash on hands of 853.69 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Guardant Health fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.68 B | 4.4 B | 1.35 B | 853.69 M |
Guardant Health Investor Information
About 95.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.28. Guardant Health had not issued any dividends in recent years. Based on the key indicators obtained from Guardant Health's historical financial statements, Guardant Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Guardant Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guardant Health has an asset utilization ratio of 31.57 percent. This signifies that the Company is making $0.32 for each dollar of assets. An increasing asset utilization means that Guardant Health is more efficient with each dollar of assets it utilizes for everyday operations.Guardant Health Ownership Allocation
The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company.Guardant Health Profitability Analysis
The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M.About Guardant Health Valuation
An absolute valuation paradigm, as applied to Guardant Stock, attempts to find the value of Guardant Health based on its fundamental and basic technical indicators. By analyzing Guardant Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Guardant Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardant Health. We calculate exposure to Guardant Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guardant Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 336.9 M | 177 M | |
| Pretax Profit Margin | (0.85) | (0.89) | |
| Operating Profit Margin | (1.00) | (1.05) | |
| Net Loss | (0.85) | (0.89) | |
| Gross Profit Margin | 0.60 | 0.43 |
Guardant Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 112 M |
Guardant Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Guardant Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Guardant we look at many different elements of the entity such as Guardant's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Guardant Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Guardant Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Guardant Health's worth.Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |